Alnylam Pharmaceuticals (ALNY) Q1 2025 Earnings

Feb 13Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.12
-0.79
-0.46
-0.13

Details

Expected EPS
-0.592096
Actual EPS
-0.65
Surprise EPS
-0.06
Surprise Percent
-9.78%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY⁩) has reported earnings of ⁦-0.65⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts